ProQR Therapeutics NV (PRQR) Aksiya narxi va yangiliklar - Google Finance

Moliya

Bosh sahifaPRQR • NASDAQ

ProQR Therapeutics NV

1,65 $

16-yan, 20:30:00 (GMT-5) · USD · NASDAQ · Ogohlantirish

Alnylam Pharmaceuticals, Inc.

359,00 $

ALNY0,093%

China SXT Pharmaceuticals Inc

0,095 $

SXTC10,46%

Diginex Ltd

2,12 $

DGNX2,30%

SMX (Security Matters) PLC

24,17 $

SMX1,21%

ICZOOM Group Inc

1,52 $

IZM0,66%

Star Fashion Culture Holdings Ltd

0,12 $

STFS1,03%

Cyclerion Therapeutics Inc

1,36 $

CYCN0,00%

Atara Biotherapeutics Inc

4,54 $

ATRA1,73%

Estrella Immunopharma Inc

0,99 $

ESLA2,47%

Mangoceuticals Inc

0,63 $

MGRX5,89%

AksiyalarAQSH qimmatli qogʻozi

Yopilish kursi

1,58 $

Kunlik diapazon

1,60 $ - 1,74 $

Yillik diapazon

1,08 $ - 3,10 $

Bozor kapitalizatsiyasi

173,82 mln USD

Oʻrtacha hajm

647,32 ming

Narx/foyda

-

Dividend daromadliligi

-

Asosiy maydon

NASDAQ

Bozor yangiliklari

Trump calls NYSE Dallas expansion plans 'unbelievably bad' for New York

NYSE-parent Intercontinental Exchange develops platform for 24/7 tokenized securities trading

Dow, S&P 500, Nasdaq futures skid after Trump threatens added European tariffs over Greenland

Detroit Free Press

Is the stock market closed Monday? See 2026 holidays

Trump Says Mamdani Facing ‘Big Test’ From NYSE’s Texas Trading Outpost

President Trump says Dallas’ ‘Y’all Street’ is bad for New York in social media post

Haqida

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. Wikipedia

CEO

Daniel A. de Boer

Tashkil etilgan

2012

Sayt

Xodimlar soni

166

Qidiruv

Qidiruv maydonini tozalash

Qidiruvni yopish

Google ilovalari

Asosiy menyu